HCA Healthcare, Inc. HCA
462.86 USD -4.87 (-1.04%)
At closeNov 3, 2026, 5:14 PM EST
462.86 0.00 0.00%
After hours · Nov 3, 5:14 PM ET
460.68 Day range 470.36
353.99 52-week range 556.52
- YTD
- -0.86%
- 1 year
- +0.28%
Analyst view
Consensus: buy
Buy
Price target (mean) 475.45 +2.7% upside
Now 462.86
- Target (low)
- 380.00
- Target (mean)
- 475.45
- Target (high)
- 550.00
Ratings (0m) 26 15 buy · 9 hold · 2 sell
- Strong buy1
- Buy14
- Hold9
- Sell1
- Strong sell1
Recommendation trend
- This month 26
- 1 month ago 26
- 2 months ago 26
- 3 months ago 25
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 8.20 | 7.88 – 8.51 | 8.01 | +2.4% | 20.02B | +2.6% | 18 |
| Next quarter | 7.55 | 6.93 – 7.96 | 7.15 | +5.6% | 19.89B | +4.1% | 12 |
| Current year | 30.16 | 29.85 – 30.43 | 28.21 | +6.9% | 79.16B | +4.7% | 17 |
| Next year | 31.29 | 29.83 – 32.50 | 30.16 | +3.7% | 81.66B | +3.2% | 22 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Nov 2, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 28, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 28, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Oct 28, 2026 | Baird | Maintained | Neutral | Neutral |
| Oct 28, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Oct 12, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 23, 2026 | BMO Capital | Initiated | — | Outperform |
| Sep 18, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Sep 8, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 20, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 3, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 28, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 28, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 27, 2026 | UBS | Maintained | Buy | Buy |
| Jul 27, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Jul 27, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 27, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 27, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jul 27, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 27, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 16, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 15, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 14, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jul 13, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 8, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
